Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm Female
Interventions: DRUG: CDK 4/6 inhibitor|DRUG: Non-Steroidal Aromatase Inhibitor|DRUG: Fulvestrant
Sponsor: Borstkanker Onderzoek Groep